95
Views
1
CrossRef citations to date
0
Altmetric
Review

A spotlight on alirocumab in high cardiovascular risk patients with type 2 diabetes and mixed dyslipidemia: a review on the emerging data

, , , , , & show all
Pages 1897-1911 | Published online: 19 Sep 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (1)